Fennec Pharmaceuticals FENC
NASDAQ FENC
$10.64 +0.06 (+0.57%)
At close: Nov 11, 2026 · 4:00 PM EST

Fennec Pharmaceuticals (FENC) Operating Leases (2023 - 2024)

Updated

Fennec Pharmaceuticals' Operating Leases came in at $2,000 for Q4 2023, down 71.4% from the prior quarter.

Analysis

Fennec Pharmaceuticals (FENC) Operating Leases (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Fennec Pharmaceuticals 370.66 Mn 230.50 Mn 17.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 2,000.00
Sep 30, 2024 7,000.00
Jun 30, 2024 12,000.00
Mar 31, 2024 17,000.00
Dec 31, 2023 2,000.00
Sep 30, 2023 7,000.00
Mar 31, 2023 21,000.00
API Access

Fennec Pharmaceuticals Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=FENC&period=max&api_key=YOUR_API_KEY